Detalles de la búsqueda
1.
Pharmacokinetics and safety study of posaconazole intravenous solution administered peripherally to healthy subjects.
Antimicrob Agents Chemother
; 59(2): 1246-51, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25512407
2.
Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy.
Eur J Clin Pharmacol
; 71(3): 303-11, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25666027
3.
Pharmacokinetic interactions between the hepatitis C virus protease inhibitor boceprevir and ritonavir-boosted HIV-1 protease inhibitors atazanavir, darunavir, and lopinavir.
Clin Infect Dis
; 56(5): 718-26, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23155151
4.
Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers.
Hepatology
; 56(5): 1622-30, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22576324
5.
Single-dose phase I study to evaluate the pharmacokinetics of posaconazole in new tablet and capsule formulations relative to oral suspension.
Antimicrob Agents Chemother
; 56(8): 4196-201, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22615291
6.
Erratum for Kersemaekers et al., Pharmacokinetics and Safety Study of Posaconazole Intravenous Solution Administered Peripherally to Healthy Subjects.
Antimicrob Agents Chemother
; 60(7): 4426, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27325815
7.
Pharmacokinetics and Safety of PTC596, a Novel Tubulin-Binding Agent, in Subjects With Advanced Solid Tumors.
Clin Pharmacol Drug Dev
; 10(8): 940-949, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33440067
8.
Effect of vicriviroc on the QT/corrected QT interval and central nervous system in healthy subjects.
Antimicrob Agents Chemother
; 54(6): 2448-54, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20350942
9.
Antiviral Activity, Safety, and Tolerability of Multiple Ascending Doses of Elbasvir or Grazoprevir in Participants Infected With Hepatitis C Virus Genotype-1 or -3.
Clin Ther
; 40(5): 704-718.e6, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29703432
10.
Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function.
Clin Pharmacol
; 9: 133-145, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29184451
11.
The effect of ravuconazole on the pharmacokinetics of nelfinavir in healthy male volunteers.
J Clin Pharmacol
; 46(2): 193-200, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16432271
12.
A Phase 1, double-blind, 4-period crossover study to investigate the effects of pomalidomide on QT interval in healthy male subjects.
Cancer Chemother Pharmacol
; 77(2): 251-8, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26754679
13.
Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies.
J Clin Pharmacol
; 56(2): 143-51, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26044116
14.
Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction.
AIDS
; 19(15): 1635-41, 2005 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-16184033
15.
The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults.
AIDS
; 18(16): 2137-44, 2004 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-15577646
16.
Effect of food on the oral bioavailability of didanosine from encapsulated enteric-coated beads.
J Clin Pharmacol
; 42(4): 419-27, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11936567
17.
Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers.
Expert Opin Drug Metab Toxicol
; 8(1): 1-10, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22176629
18.
Single-dose pharmacokinetics of boceprevir in subjects with impaired hepatic or renal function.
Clin Pharmacokinet
; 51(9): 619-28, 2012 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22799589
19.
Pharmacokinetic interaction of vicriviroc with other antiretroviral agents: results from a series of fixed-sequence and parallel-group clinical trials.
Clin Pharmacokinet
; 50(4): 267-80, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21348539
20.
Effect of vicriviroc with or without ritonavir on oral contraceptive pharmacokinetics: a randomized, open-label, parallel-group, fixed-sequence crossover trial in healthy women.
Clin Ther
; 33(10): 1503-14, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22015327